Coronavirus updates: What you need to know about COVID-19

Biosecurity

Ebola screening in Guinea in 2014.

Ebola makes a very convincing case for global cooperation

By Elisabeth Eaves | Biosecurity, What We’re Reading

DARPA’s Prepare program: Preparing for what?

By Filippa Lentzos, Jez Littlewood | Biosecurity

US service members conduct a chemical warfare exercise.

Strengthen the taboo against biological and chemical weapons

By Filippa Lentzos | Biosecurity, Chemical Weapons

Vaccine causing polio in Africa? Context from an expert

By Lucien Crowder | Biosecurity, Interviews

John Oliver takes on Crispr, with hilarious and explanatory results.

John Oliver tackles Crispr

By | Biosecurity, Disruptive Technologies, What We’re Reading

test tubes.jpeg

“Biohackers” conduct an unregulated arms race

By Lucien Crowder | Biosecurity, What We’re Reading

177472327_8_resized.jpg

The slow death of nonproliferation norms

By Charles P. Blair | Analysis, Biosecurity, Nuclear Risk, Nuclear Weapons, Technology and Security

biology-clinic-doctor-4154.jpg

How do we control dangerous biological research?

By Filippa Lentzos | Biosecurity, Synthetic biology

The dread and the awe: Crispr’s inventor assesses her creation

By Sonia Ben Ouagrham-Gormley, Saskia Popescu | Biosecurity, Book Review, Disruptive Technologies, Technology and Security

New pathogen research rules: Gain of function, loss of clarity

By Gregory D. Koblentz, Lynn C. Klotz | Analysis, Biosecurity, Disruptive Technologies, Synthetic biology

Horsepox synthesis: A case of the unilateralist’s curse?

By Gregory Lewis | Analysis, Biosecurity

Seven of 2017’s freshest perspectives on nuclear weapons, biological threats, and more

By Dawn Stover | Biosecurity, Disruptive Technologies, Nuclear Weapons, Technology and Security, Voices of Tomorrow